FDA Approves Candesartan Cilexetil for the Treatment of Heart Failure

Takeda Pharmaceutical Company Limited ("Takeda") announced today that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) candesartan cilexetil, which is sold as Atacand® by AstraZeneca in the US, for the treatment of heart failure (New York Heart Association Class II-IV and ejection fraction less ...

Continue to FDA Approves Candesartan Cilexetil for the Treatment of Heart Failure on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz